Funder
Ente Cassa di Risparmio di Firenze
Subject
Organic Chemistry,General Medicine,Biochemistry,Analytical Chemistry
Reference53 articles.
1. Cellular and molecular pathobiology of pulmonary arterial hypertension;Humbert;J. Am. Coll. Cardiol.,2004
2. A review of pulmonary arterial hypertension: role of ambrisentan;Barst;Vasc. Health Risk Manag.,2007
3. European Medicines Agency, Assessment report for Volibris Doc. Ref.: EMEA/123999/2008. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000839/WC500053063.pdf, (2008) (accessed 7.03.16).
4. Rapid determination of ambrisentan enantiomers by enantioselective liquid chromatography using cellulose-based chiral stationary phase in reverse phase mode;Douša;J. Sep. Sci.,2012
5. A validated specific stability-indicating RP-HPLC assay method for ambrisentan and its related substances;Narayana;J. Chromatogr. Sci.,2014
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献